Logo image of PXS

PYXIS TANKERS INC (PXS) Stock Fundamental Analysis

USA - NASDAQ:PXS - MHY717261306 - Common Stock

2.8 USD
-0.04 (-1.51%)
Last: 10/17/2025, 8:00:01 PM
Fundamental Rating

3

Taking everything into account, PXS scores 3 out of 10 in our fundamental rating. PXS was compared to 35 industry peers in the Marine Transportation industry. PXS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PXS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

PXS had positive earnings in the past year.
PXS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PXS reported negative net income in multiple years.
In multiple years PXS reported negative operating cash flow during the last 5 years.
PXS Yearly Net Income VS EBIT VS OCF VS FCFPXS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

The Return On Assets of PXS (-0.04%) is worse than 68.57% of its industry peers.
PXS has a worse Return On Equity (-0.08%) than 65.71% of its industry peers.
PXS has a worse Return On Invested Capital (3.09%) than 62.86% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PXS is significantly below the industry average of 18.84%.
The 3 year average ROIC (9.02%) for PXS is well above the current ROIC(3.09%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.04%
ROE -0.08%
ROIC 3.09%
ROA(3y)11.96%
ROA(5y)3.87%
ROE(3y)22.74%
ROE(5y)3.65%
ROIC(3y)9.02%
ROIC(5y)N/A
PXS Yearly ROA, ROE, ROICPXS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

PXS has a Operating Margin (15.05%) which is in line with its industry peers.
PXS's Operating Margin has improved in the last couple of years.
PXS has a Gross Margin of 50.66%. This is in the better half of the industry: PXS outperforms 65.71% of its industry peers.
In the last couple of years the Gross Margin of PXS has grown nicely.
Industry RankSector Rank
OM 15.05%
PM (TTM) N/A
GM 50.66%
OM growth 3YN/A
OM growth 5Y108.23%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y62.21%
GM growth 5Y9.32%
PXS Yearly Profit, Operating, Gross MarginsPXS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PXS is creating some value.
The number of shares outstanding for PXS remains at a similar level compared to 1 year ago.
The number of shares outstanding for PXS has been increased compared to 5 years ago.
PXS has a worse debt/assets ratio than last year.
PXS Yearly Shares OutstandingPXS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
PXS Yearly Total Debt VS Total AssetsPXS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

PXS has an Altman-Z score of 0.70. This is a bad value and indicates that PXS is not financially healthy and even has some risk of bankruptcy.
PXS has a worse Altman-Z score (0.70) than 60.00% of its industry peers.
PXS has a Debt/Equity ratio of 0.80. This is a neutral value indicating PXS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.80, PXS is doing worse than 62.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF N/A
Altman-Z 0.7
ROIC/WACC0.35
WACC8.88%
PXS Yearly LT Debt VS Equity VS FCFPXS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M

2.3 Liquidity

PXS has a Current Ratio of 3.02. This indicates that PXS is financially healthy and has no problem in meeting its short term obligations.
PXS's Current ratio of 3.02 is amongst the best of the industry. PXS outperforms 82.86% of its industry peers.
PXS has a Quick Ratio of 2.92. This indicates that PXS is financially healthy and has no problem in meeting its short term obligations.
PXS has a Quick ratio of 2.92. This is amongst the best in the industry. PXS outperforms 82.86% of its industry peers.
Industry RankSector Rank
Current Ratio 3.02
Quick Ratio 2.92
PXS Yearly Current Assets VS Current LiabilitesPXS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2

3. Growth

3.1 Past

PXS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -101.78%.
PXS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.95%.
The Revenue has been growing by 13.18% on average over the past years. This is quite good.
EPS 1Y (TTM)-101.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-144.19%
Revenue 1Y (TTM)-10.95%
Revenue growth 3Y26.7%
Revenue growth 5Y13.18%
Sales Q2Q%-34.21%

3.2 Future

PXS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.60% yearly.
PXS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.55% yearly.
EPS Next Y-73.15%
EPS Next 2Y-2.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-18.21%
Revenue Next 2Y1.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PXS Yearly Revenue VS EstimatesPXS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
PXS Yearly EPS VS EstimatesPXS Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 -2

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.73, PXS is valued correctly.
The rest of the industry has a similar Price/Earnings ratio as PXS.
PXS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.42.
PXS is valuated cheaply with a Price/Forward Earnings ratio of 2.76.
Based on the Price/Forward Earnings ratio, PXS is valued cheaply inside the industry as 97.14% of the companies are valued more expensively.
PXS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.73
Fwd PE 2.76
PXS Price Earnings VS Forward Price EarningsPXS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PXS is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.83
PXS Per share dataPXS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

PXS's earnings are expected to decrease with -2.60% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.6%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PXS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PYXIS TANKERS INC

NASDAQ:PXS (10/17/2025, 8:00:01 PM)

2.8

-0.04 (-1.51%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryMarine Transportation
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-17 2025-11-17
Inst Owners1.89%
Inst Owner Change0%
Ins Owners1.06%
Ins Owner ChangeN/A
Market Cap29.37M
Analysts80
Price Target9.18 (227.86%)
Short Float %0.47%
Short Ratio0.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.8
Dividend Growth(5Y)N/A
DP-768.06%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-183.51%
Min EPS beat(2)-318.74%
Max EPS beat(2)-48.28%
EPS beat(4)0
Avg EPS beat(4)-117.76%
Min EPS beat(4)-318.74%
Max EPS beat(4)-31.79%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-12.2%
Min Revenue beat(2)-15.55%
Max Revenue beat(2)-8.85%
Revenue beat(4)1
Avg Revenue beat(4)-5.19%
Min Revenue beat(4)-15.55%
Max Revenue beat(4)13.48%
Revenue beat(8)4
Avg Revenue beat(8)5.19%
Revenue beat(12)8
Avg Revenue beat(12)8.23%
Revenue beat(16)12
Avg Revenue beat(16)15.42%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.85%
EPS NY rev (1m)0%
EPS NY rev (3m)-46.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.64%
Valuation
Industry RankSector Rank
PE 12.73
Fwd PE 2.76
P/S 0.66
P/FCF N/A
P/OCF 1.87
P/B 0.32
P/tB 0.32
EV/EBITDA 3.83
EPS(TTM)0.22
EY7.86%
EPS(NY)1.02
Fwd EY36.25%
FCF(TTM)-2.84
FCFYN/A
OCF(TTM)1.5
OCFY53.51%
SpS4.25
BVpS8.77
TBVpS8.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.04%
ROE -0.08%
ROCE 3.92%
ROIC 3.09%
ROICexc 4.08%
ROICexgc 4.08%
OM 15.05%
PM (TTM) N/A
GM 50.66%
FCFM N/A
ROA(3y)11.96%
ROA(5y)3.87%
ROE(3y)22.74%
ROE(5y)3.65%
ROIC(3y)9.02%
ROIC(5y)N/A
ROICexc(3y)11.46%
ROICexc(5y)N/A
ROICexgc(3y)11.46%
ROICexgc(5y)N/A
ROCE(3y)11.42%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y113.74%
ROICexc growth 3YN/A
ROICexc growth 5Y113.74%
OM growth 3YN/A
OM growth 5Y108.23%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y62.21%
GM growth 5Y9.32%
F-Score4
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF N/A
Debt/EBITDA 5.13
Cap/Depr 601.69%
Cap/Sales 102.04%
Interest Coverage 1.12
Cash Conversion 110.13%
Profit Quality N/A
Current Ratio 3.02
Quick Ratio 2.92
Altman-Z 0.7
F-Score4
WACC8.88%
ROIC/WACC0.35
Cap/Depr(3y)423.68%
Cap/Depr(5y)429.93%
Cap/Sales(3y)53.82%
Cap/Sales(5y)66.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-101.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-144.19%
EPS Next Y-73.15%
EPS Next 2Y-2.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.95%
Revenue growth 3Y26.7%
Revenue growth 5Y13.18%
Sales Q2Q%-34.21%
Revenue Next Year-18.21%
Revenue Next 2Y1.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-67.83%
EBIT growth 3YN/A
EBIT growth 5Y135.68%
EBIT Next Year-58.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-250.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-20.5%
OCF growth 3YN/A
OCF growth 5Y27.2%